We use cookies to ensure that our site works correctly and provides you with the best experience. If you continue using our site without changing your browser settings, we'll assume that you agree to our use of cookies. Find out more about the cookies we use and how to manage them by reading our cookies policy. Hide

Current Issue

5th September 2019
Selected Chemistry & Industry magazine issue

Select an Issue


C&I e-books

C&I e-books

C&I apps

iOS App
Android App


Movers and shakers


US biopharmaceutical company Verastem Oncology has appointed member of the board of directors Brian Stuglik as CEO. Stuglik has over 30 years’ experience of pharmaceutical development, product strategy and commercialisation in oncology.

Read more
C&I Click to view our flipbook